These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6545591)

  • 1. [Evaluation of the efficacy and tolerance of ceftriaxone in childhood].
    Dellepiane RM; Maltagliati F; Ogliari MT
    Pediatr Med Chir; 1984; 6(6):785-9. PubMed ID: 6545591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of ceftriaxone in urinary and respiratory tract infections].
    Papierkowski A; Pietraszek-Mamcarz J; Kozłowska T; Górnicka G; Emeryk A
    Pol Tyg Lek; 1990 Apr 2-9; 45(14-15):300-2. PubMed ID: 2235713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative clinical evaluation of ceftriaxone in treating lower respiratory tract infections.
    Abbate GF; Alagia I; Giaquinto E; Leonessa V; Caputi M; Guarino C; Micillo E; Catena E; Altucci P
    Chemioterapia; 1986 Feb; 5(1):26-32. PubMed ID: 3955779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic treatment for urinary tract infections in pediatric patients.
    Hellerstein S
    Minerva Pediatr; 2003 Oct; 55(5):395-406. PubMed ID: 14608263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-daily administration of ceftriaxone for the treatment of selected serious bacterial infections in children.
    Frenkel LD
    Pediatrics; 1988 Sep; 82(3 Pt 2):486-91. PubMed ID: 3405685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient treatment of serious community-acquired pediatric infections using once daily intramuscular ceftriaxone.
    Dagan R; Phillip M; Watemberg NM; Kassis I
    Pediatr Infect Dis J; 1987 Dec; 6(12):1080-4. PubMed ID: 3324038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
    Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
    Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
    Arguedas A; Cespedes J; Botet FA; Blumer J; Yogev R; Gesser R; Wang J; West J; Snyder T; Wimmer W;
    Int J Antimicrob Agents; 2009 Feb; 33(2):163-7. PubMed ID: 18945594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International experiences with ceftriaxone in the treatment of lower respiratory tract infections.
    Grassi C; Mangiarotti P
    Chemioterapia; 1987 Oct; 6(5):364-73. PubMed ID: 3322589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cefotaxime in childhood infections (author's transl)].
    Garnier JM; Giraud F
    Nouv Presse Med; 1981 Feb; 10(8):629-33. PubMed ID: 6259608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies on ceftriaxone in complicated urinary tract infections].
    Yamakawa K; Hioki T; Kawamura J
    Hinyokika Kiyo; 1989 Feb; 35(2):377-82. PubMed ID: 2735247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of recent bacterial isolates to cefdinir and selected antibiotics among children with urinary tract infections.
    Bonsu BK; Shuler L; Sawicki L; Dorst P; Cohen DM
    Acad Emerg Med; 2006 Jan; 13(1):76-81. PubMed ID: 16365328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and bacteriologic efficacy of ceftriaxone in the United States.
    McCloskey RV
    Am J Med; 1984 Oct; 77(4C):97-103. PubMed ID: 6093528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary tract infections: evaluation and treatment.
    Bagga A
    Indian J Pediatr; 2001 Jul; 68 Suppl 3():S40-5. PubMed ID: 11980458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of azthreonam in severe urinary tract infections].
    Guibert J; Acar JF; Miegi M
    Pathol Biol (Paris); 1984 May; 32(5):446-9. PubMed ID: 6377208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Community acquired urinary tract infection among hospitalized children in northern Israel: pathogens, susceptibility patterns and urinary tract anomalies].
    Sakran W; Miron D; Halevy R; Colodner R; Smolkin V; Koren A
    Harefuah; 2003 Apr; 142(4):249-52, 320, 319. PubMed ID: 12754871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ceftriaxone or combined cefazolin-gentamicin for complicated urinary tract infections].
    Landau Z; Feld S; Krupsky M
    Harefuah; 1990 Feb; 118(3):152-3. PubMed ID: 2341068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia.
    Pertel PE; Bernardo P; Fogarty C; Matthews P; Northland R; Benvenuto M; Thorne GM; Luperchio SA; Arbeit RD; Alder J
    Clin Infect Dis; 2008 Apr; 46(8):1142-51. PubMed ID: 18444848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.